Christoph Brackmann
At a glance: Christoph Brackmann is CFO at NovoCure (NVCR). Their latest SEC Form 4, filed Nov 12, 2026, reported a sale of $94K. On file: 0 purchase lines ($0) and 2 sale lines ($180K).
Disclosed holdings: about $1.9M of NVCR stock: 175,499 shares reported on their latest Form 4 (filed Nov 12, 2026), valued at the Nov 19, 2026 close of $10.65. This counts only NVCR shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
CFO at NovoCure Ltd (NVCR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Christoph Brackmann's InsiderPrint
3 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Mostly sells, trading about 2 times a year, typically $94K a trade; often buys after the stock has fallen 15% or more.
- Bump outward: a purchase (1)
- Dent inward: a sale (2)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- W. Brian KretzmerDirector · ZD · 100% match
- Naimish PatelChief Medical Officer · CRSP · 100% match
- Robert Alan DeanDirector · PPTA · 99% match
- Robert Edward HensleyEvp & Chief Investment Officer · GL · 99% match
- Mitchell Young WilliamsChief Investment Officer · STEX · 98% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
Follow Christoph Brackmann
Get one email when Christoph Brackmann files a new purchase or sale. Free.
At most one email a day about Christoph Brackmann, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.